Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Traps to catch unwary oncogenes

A O Hueber1, G I Evan

  • 1Biochemistry of the Cell Nucleus Laboratory, Imperial Cancer Research Fund, London, UK. a.hueber@icrf.icnet.uk

Trends in Genetics : TIG
|October 14, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin.

Cell death & disease·2015
Same author

The kinetics of ER fusion protein activation in vivo.

Oncogene·2014
Same author

Interferon decreases VEGF levels in patients with chronic myeloid leukemia treated with imatinib.

Leukemia research·2014
Same author

Sequential Cdk1 and Plk1 phosphorylation of protein tyrosine phosphatase 1B promotes mitotic cell death.

Cell death & disease·2013
Same author

Synthesis of peptides for use as immunogens.

Methods in molecular biology (Clifton, N.J.)·2012
Same author

Production and characterization of antibodies against synthetic peptides.

Methods in molecular biology (Clifton, N.J.)·2012

The MYC proto-oncogene regulates cell growth and its abnormal activity is linked to cancer. MYC, RAS, and BCL2 oncogenes work together to promote cell proliferation and block cell death during cancer development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • The MYC proto-oncogene is crucial for normal cell growth.
  • MYC deregulation is a key factor in neoplasia development.
  • MYC protein influences cell proliferation and apoptosis signaling pathways.

Purpose of the Study:

  • To discuss the synergistic roles of cooperating oncogenes in carcinogenesis.
  • To explore the interplay between MYC, RAS, and BCL2 in cancer development.

Main Methods:

  • Literature review and discussion of existing research on MYC, RAS, and BCL2.
  • Analysis of signaling pathways involved in cell proliferation and apoptosis.
  • Examination of genetic lesions contributing to carcinogenesis.

Related Experiment Videos

Main Results:

  • Genetic lesions suppressing cell death and promoting cell proliferation exhibit synergy during carcinogenesis.
  • Cooperating oncogenes like MYC, RAS, and BCL2 contribute to this synergistic effect.
  • The tightly coupled nature of cell death and proliferation pathways facilitates cancer progression.

Conclusions:

  • The interplay between MYC, RAS, and BCL2 highlights a critical mechanism in cancer development.
  • Understanding this synergy is vital for developing targeted cancer therapies.
  • Targeting cooperating oncogenes offers a potential strategy for cancer treatment.